Cover Image

A case of paradoxical fibrosis and development of morphea in a patient on dupilumab

Saved in:

Bibliographic Details
Main Authors:	Bina Kassamali, BA (Author), Scott A. Elman, MD (Author), Anthony R. Sheets, MD, PhD (Author), Avery H. LaChance, MD, MPH (Author), Joseph F. Merola, MD, MMSc (Author)
Format:	Book
Published:	Elsevier, 2021-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Tocilizumab for refractory morphea in adults: A case series
by: Sarah Lonowski, MD, MBA, et al.
Published: (2022)

Exploring Dermatomyositis through an Interdisciplinary Lens: Pearls from Dermatology and Rheumatology
by: Bina Kassamali, BA, et al.
Published: (2021)

Characteristics and treatment of silicone granulomas: A retrospective multicenter cohort of 21 patients
by: Bina Kassamali, BA, et al.
Published: (2021)

A case of paradoxical eosinophilic fasciitis in a patient on benralizumab
by: Michael J. Woodbury, BS, et al.
Published: (2023)

Extension-elicited blanching of the dorsal phalanges in systemic sclerosis: A case series
by: Elisa M. Schunkert, MD, et al.
Published: (2022)

Recalcitrant Hailey-Hailey disease successfully treated with topical ruxolitinib cream and dupilumab
by: Juna Khang, BA, et al.
Published: (2023)

Association of lichen sclerosus and morphea with immune checkpoint therapy: a systematic review
by: Leah Shin, BA, et al.
Published: (2023)

Morphea-like subcutaneous panniculitis-like T-cell lymphoma
by: Keiko Tokuchi, MD, PhD, et al.
Published: (2024)

Paraneoplastic morphea with prominent mucin deposition
by: Ahmad B. Shahin, BS, et al.
Published: (2023)

A novel variant in the GNAS complex locus causes Albright hereditary osteodystrophy with pseudopseudohypoparathyroidism
by: Jeffrey S. Smith, MD, PhD, et al.
Published: (2022)

Durvalumab-associated generalized morphea with overlapping vitiligo
by: Julianna Martel, MD, et al.
Published: (2022)

Apremilast as a treatment for morphea: A case series
by: Merav Koschitzky, BA, et al.
Published: (2022)

Pilot use of 3-dimensional photography to aid clinical decision-making in craniofacial morphea
by: Ingrid M. Ganske, MD, MPA, et al.
Published: (2022)

A rare presentation of cutaneous T-cell lymphoma mimicking morphea
by: Beverly Yu, BA, BS, et al.
Published: (2023)

Pemphigoid gestationis treated with dupilumab
by: Rita E. Chen, BA, et al.
Published: (2023)

Vitiligo during dupilumab therapy
by: Vincenzo Picone, MD, et al.
Published: (2023)

Generalized morphea/eosinophilic fasciitis overlap after epoxy exposure
by: Warren H. Chan, MS, et al.
Published: (2018)

Dupilumab-induced erythema nodosum
by: Danielle E. Mustin, MEng, et al.
Published: (2022)

Morphea-like lesions after botulinum toxin A injections
by: Marina Landau, MD, et al.
Published: (2020)

Physician values in alopecia areata treatment decision-making: A qualitative assessmentCapsule Summary
by: Jane J. Han, MD, et al.
Published: (2023)

Superficial morphea: A rare condition and report of three unique cases
by: Kanthi Bommareddy, BSc, et al.
Published: (2021)

Classifying discoid lupus erythematosus: background, gaps, and difficulties
by: Jessica S. Haber, BA, et al.
Published: (2017)

Classifying discoid lupus erythematosus: background, gaps, and difficulties
by: Jessica S. Haber, BA, et al.
Published: (2016)

Patient crowdfunding for inflammatory skin disease
by: Nathaniel Goldman, BA, et al.
Published: (2022)

Rapid response of refractory subacute cutaneous lupus after single dose anifrolumab
by: Rebecca G. Gaffney, MD, et al.
Published: (2024)

Recalcitrant palmoplantar pustulosis controlled with dupilumab
by: Hannah D. Smith, BA, et al.
Published: (2023)

A case of generalized morphea profunda following SARS-CoV-2 infection
by: Michael R. Stephens, MD, et al.
Published: (2022)

A case report of uveitis secondary to dupilumab treatment for atopic dermatitis
by: Marissa Ayasse, BS, et al.
Published: (2021)

Frontal bone loss following coronal brow lift: A mimicker of head variant linear morphea
by: Maha Kazmi, BS, et al.
Published: (2023)

Peristomal irritant contact dermatitis treated with dupilumab
by: Emma Villamaria, BSA, et al.
Published: (2023)

Dupilumab, incontinentia pigmenti, and alopecia: A serendipitous observation
by: Ashley Torkan Zilberstein, MD, et al.
Published: (2022)

Angioimmunoblastic T-cell lymphoma unmasked by treatment with dupilumab
by: Zi-Yi Choo, BS, et al.
Published: (2023)

Ulcerative injection-site reaction associated with dupilumab therapy
by: Michael Phan, BS, et al.
Published: (2020)

Exacerbation of IgA nephropathy in a patient receiving dupilumab
by: Masako Yamamoto, MD, et al.
Published: (2022)

Treatment of lichen sclerosus and hypertrophic scars with dupilumab
by: Danielle M. Peterson, MD, et al.
Published: (2022)

Dupilumab: One therapy to treat multiple atopic diseases
by: Fatima Bawany, BA, et al.
Published: (2020)

Recalcitrant bullous pemphigoid responsive to dupilumab in an adolescent patient
by: Albert E. Zhou, MD, PhD, et al.
Published: (2022)

Intravenous immunoglobulin-refractory necrobiotic xanthogranuloma successfully treated with tofacitinib 2% cream
by: Neda Shahriari, MD, et al.
Published: (2023)

Dupilumab-induced pityriasis rosea
by: Morgan Zabel, BS, et al.
Published: (2023)

Novel posterior auricular cutaneous reaction after antiâTNF-Î± infusion in young women with Crohn's disease
by: Lauren N. Ko, BA, MEd, et al.
Published: (2017)